Kevin C. Lilly - Jul 28, 2022 Form 3 Insider Report for JELD-WEN Holding, Inc. (JELD)

Role
Interim CEO
Signature
/s/ Roya Behnia as attorney-in-fact for Kevin C Lilly
Stock symbol
JELD
Transactions as of
Jul 28, 2022
Transactions value $
$0
Form type
3
Date filed
8/5/2022, 04:23 PM
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JELD Common Stock 43.6K Jul 28, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JELD Common Stock Option (Right to Buy) Jul 28, 2022 Common Stock 4.5K $20.96 Direct F2
holding JELD Common Stock Option (Right to Buy) Jul 28, 2022 Common Stock 7.94K $24.54 Direct F3
holding JELD Common Stock Option (Right to Buy) Jul 28, 2022 Common Stock 10.2K $29.01 Direct F3
holding JELD Common Stock Option (Right to Buy) Jul 28, 2022 Common Stock 12.4K $24.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction includes the following awards made in respect of the issuer's common stock, the vesting of which is subject to the reporting person's continued employment with the issuer: (i) 3,056 restricted stock units granted on February 11, 2020, which shall vest on February 11, 2023, (ii) 5,687 restricted stock units granted on February 23, 2021, which shall vest on February 23, 2024, (iii) 5,079 restricted stock units granted on February 23, 2021, which shall vest one-third annually over a three-year period beginning on the first anniversary of the grant date, and (iv) 28,899 restricted stock units granted on February 16, 2022, which shall vest one-third annually over a three-year period beginning on the first anniversary of the grant date.
F2 The options vested fully on February 25, 2022.
F3 Subject to the reporting person's continued employment with the issuer, the options will vest one-third annually over a three-year period beginning on the first anniversary of the grant date.